The NMNAT1 gene helps cells make NAD, a molecule they need for energy, repair, and day to day survival. This gene plays an important role in protecting the retina, the light sensing tissue at the back of the eye. If the gene does not work properly, retinal cells may stop working and gradually break down, which can lead to inherited vision conditions such as Leber congenital amaurosis and, in some people, cone rod dystrophy. NMNAT1 is mainly known in eye genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they take place, and how strongly they are active. Taken together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
NMNAT1Gene function
What if the gene works
The NMNAT1 gene helps cells make NAD, a molecule they need for energy use and DNA repair. It is especially active in the cell nucleus, where it supports healthy cell function, including in the retina.
Risk
What if the gene does not work
Biallelic variants in the NMNAT1 gene most often cause inherited retinal disease, especially Leber congenital amaurosis, with vision loss from infancy or childhood. Milder and more severe variants can influence when it starts, how much vision is affected, and whether developmental, bone, or hearing features appear.
Treatment
What does that mean for your treatment
No NMNAT1-specific treatment or drug selection approach is currently established in clinical guidelines for pathogenic variants in the NMNAT1 gene. Early research is exploring gene replacement and other retina-focused therapies for NMNAT1-related inherited retinal disease, but these approaches are not yet standard care.
Conditions associated with NMNAT1
Gene function
What if the gene works
Inside your cell nucleus, the NMNAT1 gene helps keep an essential cell helper called NAD available. NAD supports routine jobs such as energy use in the nucleus, DNA repair, and control of gene activity. Understanding what the NMNAT1 gene does in cells helps show how your cells keep everyday nuclear work running smoothly.
The NMNAT1 gene helps make NAD (a helper molecule cells need for energy and repair) inside the nucleus. It joins smaller building blocks together so the nucleus has a steady local supply.
This nuclear NAD supply supports proteins that respond to normal DNA wear and tear. It helps cells carry out DNA repair steps in a controlled way while genetic material is being used and copied.
NMNAT1 also supports enzymes that help regulate which genes are active at a given time. This helps the nucleus coordinate routine cell activity and maintain normal cell function.
What is a variant?
A genetic variant is a small change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Pathogenic variants in the NMNAT1 gene linked to retinal disease often make the protein less stable or less active, so cells produce less NAD+ (a molecule needed for energy and cell repair). Some variants mainly lower enzyme activity, while more disruptive variants can sharply reduce the amount of working protein or stop it from being made at all. This severity range can influence how strongly cell function is affected and, in established NMNAT1-related eye disease, may contribute to earlier onset or more pronounced vision loss.
How variants are linked to conditions
Pathogenic variants in the NMNAT1 gene are linked to Leber congenital amaurosis type 9, an inherited eye condition that causes severe vision loss from infancy or early childhood. When pathogenic variants are present in both copies of the NMNAT1 gene, they can confirm this diagnosis. A small number of people with NMNAT1-related disease have also had a broader condition with vision loss plus hearing, bone, or developmental differences.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NMNAT1, risk is mainly shaped by inheritance: people usually develop related eye disease only when they inherit harmful changes in both copies of the gene. A family history of the condition or parents who are related by blood can raise the chance of this happening.
Inheritance of NMNAT1 variants
NMNAT1-related conditions are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two NMNAT1 variants, one from each parent, to have the condition. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In practical terms, NMNAT1 inheritance usually means the condition can appear in a child even when there is no family history of vision loss.
What does my NMNAT1 result mean for my family?
For families with an NMNAT1-related condition, parents are often healthy carriers, and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change runs in the family, especially if there is a history of severe vision loss starting in infancy or early childhood. The main family impact is usually around carrier status and the chance of having another child with the condition.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked with inherited retinal disease, NMNAT1 genetic testing uses a blood or saliva sample to read the NMNAT1 gene. Labs usually use sequencing, which reads the DNA code, and may also check for missing or extra pieces. Results can show whether a variant in the NMNAT1 gene is present.
When should I consider getting a genetic test?
You may consider testing the NMNAT1 gene if a baby or child has very poor vision from birth or early infancy, especially with wandering eye movements or a family history of inherited eye disease. Testing can help confirm a genetic cause and clarify carrier status for relatives planning a family.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it reveals depends on the condition and the specific type of variant involved. How the body works over time is also influenced by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medicines. It focuses on links between genes and drugs to help explain why the same treatment works differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body handles it. This information can support more informed and more individualized treatment decisions. If you want to learn more about this topic, you can find additional information in the LearnHub.
Drugs influenced by the NMNAT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about medication response, side effects, or treatment changes are best discussed with your doctor.
History
Researchers identified the NMNAT1 gene in the late 1990s while mapping human genes involved in making NAD, a molecule cells need to work normally. Early laboratory studies helped place NMNAT1 within a small gene family, which gave scientists a clearer framework for later disease research. A major milestone came in 2007, when harmful variants in the NMNAT1 gene were linked to a form of Leber congenital amaurosis, an inherited condition that affects vision from infancy. From these first observations, research expanded steadily. That discovery clarified the cause of disease in some families who had long searched for an answer. Since then, NMNAT1 has remained important in studies of inherited retinal conditions and how genetic findings can sharpen diagnosis.